BSTE: Could this be one of the reasons? Wachovia Reit Outperform We are increasing our EPS forecast for BSTE by $0.03 for Q204 and $0.05 for the full year 2004 based on our assumption of more robust BNP market growth and a muted competitive impact form Abbott. Our model calls for Biosite to grow its U.S. BNP volumes at a conservative 30% clip in a 100% growth market for the balance of the year, its market share should be in the 50% to 60% range by year end.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.